Ausdal Financial Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,359
Closed -$334K 347
2019
Q3
$334K Sell
3,359
-60
-2% -$5.7K 0.12% 215
2019
Q2
$317K Hold
3,419
0.12% 201
2019
Q1
$323K Hold
3,419
0.13% 191
2018
Q4
$219K Sell
3,419
-1,812
-35% -$134K 0.11% 216
2018
Q3
$468K Sell
5,231
-1,021
-16% -$90.2K 0.13% 207
2018
Q2
$497K Buy
6,252
+291
+5% +$24.2K 0.15% 192
2018
Q1
$532K Buy
5,961
+2,293
+63% +$220K 0.18% 166
2017
Q4
$383K Buy
3,668
+765
+26% +$86.3K 0.14% 211
2017
Q3
$423K Buy
2,903
+60
+2% +$8.17K 0.17% 172
2017
Q2
$369K Buy
2,843
+369
+15% +$45.2K 0.16% 179
2017
Q1
$308K Buy
+2,474
New +$296K 0.14% 192
2016
Q1
Sell
-556
Closed -$67K 1315
2015
Q4
$67K Buy
+556
New +$64.3K 0.03% 384

Other funds holding CELG

Ausdal Financial Partners's CELG Position: Q4 2019 in Review

Ausdal Financial Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,359 shares — an estimated $334K sold.

Ausdal Financial Partners first reported a position in CELG in Q4 2015 and held it in 12 quarters. The position peaked at $532K in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ausdal Financial Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ausdal Financial Partners sold 3,359 Celgene Corp shares in Q4 2019, an estimated $334K.
  • Ausdal Financial Partners first reported a position in Celgene Corp in Q4 2015 and held it in 12 quarters.
  • Ausdal Financial Partners's Celgene Corp position peaked at $532K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ausdal Financial Partners's 13F filing for Q4 2019, filed 14 Feb 2020.